Who
David Francisco
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Organogenesis Holdings.
In numbers
- Trades disclosed
- 43
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Feb 2021
- Last trade
- 18 Feb 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —44,040 at $0.00 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $56K14,687 at $3.84 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —44,040 at $0.00 | filing |
| 18 Feb 2026filed 3 Mar 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $56K14,687 at $3.84 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —195,312 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —43,602 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $56K14,541 at $3.84 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —111,358 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —111,358 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —195,312 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code A | —43,602 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $56K14,541 at $3.84 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $15K3,898 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $80K21,412 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $50K13,369 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $51K13,769 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $15K3,898 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $80K21,412 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $50K13,369 at $3.73 | filing |
| 15 Feb 2026filed 18 Feb 2026 | ORGO Organogenesis HoldingsBiotechnology | SEC FORM 4 Code F | $51K13,769 at $3.73 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.